A new oral antifungal (oteseconazole) specifically indicated for the treatment of RVVC was approved
in the United States in April 2022 and is currently on fast-track, priority review by Health Canada.
All along the boardwalk of Puerto Vallarta and other popular vacation spots, Canadian tourists will see farmacias with white-washed walls and signs offering erectile dysfunction drugs and other products.
We asked the co-CEO, OnPharm-United and President, FIP—Community Pharmacy Section about everything from his favourite foods and his favourite career moments.